Dawnrays Pharmaceutical (Holdings) Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Liwei Yu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 18.2yrs |
| Board average tenure | 16.5yrs |
Recent management updates
Recent updates
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem
Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 11Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065
May 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065
Apr 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065
Apr 08Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23CEO
Liwei Yu (54 yo)
less than a year
Tenure
Ms. Liwei Yu is Chief Executive Officer of Dawnrays Pharmaceutical (Holdings) Limited from September 13, 2024. Ms. Yu is the Chief Human Resources Officer of the Group and fully responsible for the human r...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 29.8yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Chief Executive Officer | less than a year | no data | no data | |
| Chief Financial Officer | 6.6yrs | no data | no data | |
| Company Secretary | no data | no data | no data |
18.2yrs
Average Tenure
60yo
Average Age
Experienced Management: 2348's management team is seasoned and experienced (18.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 22.1yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Independent Non-Executive Director | 9.4yrs | CN¥326.00k | no data | |
| Non-Executive Director | 19yrs | CN¥271.00k | no data | |
| Independent Non-Executive Director | 14.1yrs | CN¥326.00k | no data | |
| Independent Non-Executive Director | 6.5yrs | CN¥326.00k | no data |
16.5yrs
Average Tenure
60.5yo
Average Age
Experienced Board: 2348's board of directors are seasoned and experienced ( 16.5 years average tenure).